Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Mahner · SciRah

Researcher profile · Semantic Scholar

S. Mahner

Share profile

S. Mahner — researcher profile on SciRah

h-index: 65
Works: 1,072
Citations: 20K

Most-cited papers

TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7).
S. Mahner, F. Heitz, Sahar Salehi, A. Reuss +16 more
2025Journal of Clinical Oncology34 citations Open access
Semantic Scholar
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety.
U. Matulonis, J. Herrstedt, A. Oza, S. Mahner +17 more
2025Gynecologic Oncology15 citations
Semantic Scholar
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis
F. Trillsch, B. Czogalla, S. Mahner, V. Loidl +16 more
2025International Journal of Surgery11 citations Open access
Semantic Scholar
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy
A. Reischer, A. Leutbecher, B. Hiller, Enrico D. Perini +18 more
2025Cancer Immunology and Immunotherapy10 citations Open access
Semantic Scholar
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk
R. Watrowski, E. Schuster, Stefan Polterauer, T. van Gorp +5 more
2025Life8 citations Open access
Semantic Scholar
Intergroup statement: opportunistic salpingectomy—molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss)
M. Pölcher, P. Wimberger, I. Meinhold-Heerlein, I. Runnebaum +6 more
2025Archives of Gynecology and Obstetrics7 citations Open access
Semantic Scholar
127TiP An open-label, randomized, multicenter, phase III study of trastuzumab deruxtecan (T-DXd) with bevacizumab (BEV) vs BEV monotherapy as first-line (1L) maintenance therapy in HER2-expressing ovarian cancer: DESTINY-Ovarian01 (DO 01)
A. González-Martín, J. M. Tran Janco, J-Y. Lee, D. Lorusso +8 more
2025ESMO Open6 citations Open access
Semantic Scholar
Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group - Real-world observations.
P. Wimberger, Jacobus Pfisterer, A. du Bois, F. Hilpert +11 more
2025European Journal of Surgical Oncology5 citations Open access
Semantic Scholar
Surgical approach, preoperative LEEP/conization and patterns of recurrence and death in low-risk cervical cancer – exploratory analysis from the CCTG CX.5/SHAPE trial
S. Mahner, F. Trillsch, Janice S. Kwon, Sarah E. Ferguson +17 more
2025International Journal of Surgery5 citations Open access
Semantic Scholar
Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer
M. Zheng, Mirjana Kessler, U. Jeschke, Juliane Reichenbach +7 more
2025Cancers5 citations Open access
Semantic Scholar
PROM at term: when might be the best time to induce labour? A retrospective analysis
T. Starrach, L. Ehmann, Hannah Volkmann, A. Flemmer +9 more
2025Archives of Gynecology and Obstetrics3 citations Open access
Semantic Scholar
GANNET53 Part II: A European Phase I/II Trial of the HSP90 inhibitor Ganetespib in high-grade Platinum-Resistant Ovarian Cancer - A Study of the GANNET53 consortium.
N. Concin, I. Braicu, Pierre Combe, R. Berger +22 more
2025Clinical Cancer Research3 citations
Semantic Scholar
Influence of breast cancer on life satisfaction in the elderly patient
M. Burgmann, K. Hermelink, A. Lotz, V. Schlager +9 more
2025Archives of Gynecology and Obstetrics3 citations Open access
Semantic Scholar
Ablation compared with excision in the surgical management of peritoneal endometriosis: a retrospective study of pain, re-operation, and pregnancy outcomes
T. Kolben, Lennard Schröder, Charlene Kaiser-Rix, S. Mahner +9 more
2026Archives of Gynecology and Obstetrics2 citations Open access
Semantic Scholar
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/ SHAPE trial.
Se Ik Kim, Jae-Weon Kim, Janice S. Kwon, Sarah E. Ferguson +18 more
2026Gynecologic Oncology2 citations Open access
Semantic Scholar
Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer
L. Chinczewski, P. Harter, Lukas C Heukamp, Doris Mayr +8 more
2025Archives of Gynecology and Obstetrics2 citations Open access
Semantic Scholar
TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33 / AGO-OVAR OP7)
B. Mosgaard, Florian Heitz, G. Aletti, A. Reuss +16 more
2026International Journal of Gynecological Cancer1 citations
Semantic Scholar
Now or Later? Defining the Ideal Time for Surgical Cytoreduction in Advanced Ovarian Cancer.
Kristin Bixel, A. Olawaiye, Margaret R Flanigan, Paulina J. Haight +2 more
2026American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting1 citations
Semantic Scholar
Simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: an exlploratory analysis from the GCIG/CCTG CX.5/SHAPE trial
Se Ik Kim, Jae-Weon Kim, Janice S. Kwon, Sarah E. Ferguson +18 more
2026International Journal of Gynecological Cancer1 citations
Semantic Scholar
Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancer
Juliane Reichenbach, Juliana Schmid, Sophia Hierlmayer, Ting-Yu Zhang +16 more
2025iScience1 citations Open access
Semantic Scholar
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study).
Melisa Guelhan Inci, Ebru İlter, E. Roser, D. Dimitrova +21 more
2025International Journal of Gynecological Cancer1 citations Open access
Semantic Scholar
A low nuclear-to-cytoplasmic ratio of VDR expression is an independent prognostic marker in breast cancer.
Charlotte Schubert, T. Vilsmaier, F. Batz, V. Cavaillès +10 more
2025Histology and Histopathology1 citations
Semantic Scholar
Breast cancer in patients under 40 years: an 11-year retrospective cohort analysis
F. Ganster, S. Schrodi, M. Braun, C. Seifert +5 more
2025Archives of Gynecology and Obstetrics1 citations Open access
Semantic Scholar
Fetal Cardiac Magnetic Resonance Imaging in Left-Sided Diaphragmatic Hernia
Gloria Biechele, Nicola Fink, Julien Dinkel, Ryoko Mehnert +7 more
2025JACC Case Reports1 citations
Semantic Scholar
Potential of tumor-informed ctDNA as an early predictive indicator for relapse in advanced ovarian cancer.
C. Tauber, F. Trillsch, M. Postl, Valentina Glueck +12 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Satisfaction with Breastfeeding and Not Frequency of Feeding is Associated with a Reduction of Postpartum Depressive Symptoms
Laura Hahn, Eva-Maria Dreyer, Marilena Thomann, S. Beyer +6 more
2025Breastfeeding Medicine1 citations
Semantic Scholar
Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.
A. Jaeger, M. Hampl, K. Prieske, C. Eulenburg +36 more
2025Gynecologic Oncology1 citations Open access
Semantic Scholar
73MO Treatment and outcome of elderly patients with early ovarian cancer in Germany: QS ovar of the AGO study group
F. Hilpert, J. Pfisterer, A. du Bois, S. Mahner +10 more
2025ESMO Open1 citations Open access
Semantic Scholar
Abstract B086: Anchored in Resistance: Overcoming Nidogen-2 (NID2) - mediated Immunoresistance in Ovarian Cancer with Ras and Bcl-xl Inhibition
Fabian Kraus, Meng-Yao Xu, Raj Kumar, Irva E Veillard +11 more
2025Molecular Cancer Therapeutics1 citations
Semantic Scholar
Olaparib-Response in humanen OVCA-Organoiden: Unterschiedliche Downstream-Signalantworten trennen Responder von Non-Respondern
S. Geweniger, Y. Shi, B. Czogalla, F. Kraus +5 more
2026Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
Abstract 1061: Tumor-informed circulating tumor DNA identifies high-grade serous ovarian cancer patients at highest risk for recurrence despite optimal first-line treatment with primary macroscopic complete resection
M. Postl, C. Tauber, Valentina Glueck, M. Gliga +14 more
2026Cancer Research0 citations
Semantic Scholar
Preoperative endocrine treatment response in primary postmenopausal endometrial cancer.
F. Trillsch, S. Mahner, Angelina Vlaški, Mara Franzl +9 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Eutopic echoes ectopic: organoid-based evidence of shared hormone dysregulation in endometriosis
J. Cioraityte, Lennard Schröder, Zeinesh Beimenbetova, Anna T. Rückl +6 more
2026Reproductive Biology and Endocrinology0 citations
Semantic Scholar
Association between ki67 expression and molecular subgroups of endometrial carcinoma
Mara Franzl, A. Chelariu-Raicu, Angelina Vlaški, Doris Mayr +7 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
Impact of Anatomical Site on RNA-Based Molecular Subtypes in Paired High-Grade Serous Ovarian Carcinoma Samples
Karolin Heinze, Tia S. Murdoch, Evan S. Cairns, D. Chiu +8 more
2026Cancers0 citations Open access
Semantic Scholar
TP53 mutational status correlates with PD-L1 and L1CAM expression in uterine serous carcinoma
Angelina Vlaški, Mara Franzl, R. Gronauer, H. Fiegl +11 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
Correlation of pelvic magnetic resonance imaging with diagnostic loop electrosurgical excision procedure/cone biopsy and hysterectomy pathology: an exploratory analysis of the CX.5/SHAPE trial.
Marie Plante, Janice S. Kwon, S. Mahner, Béatrice Cormier +16 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
Daten zum Ovarialkarzinom mit klinischen Auswirkungen
Fabian Trillsch, S. Mahner
2026Gynäkologie + Geburtshilfe0 citations
Semantic Scholar
Begrenzte Resistenzentwicklung unter Paclitaxel im Organoidmodell des high-grade serösen Ovarialkarzinoms
J. Reichenbach, L. Mendl, A. Chelariu-Raicu, F. Kraus +4 more
2026Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
A Mobile Exhibition to Advance Cancer Prevention Awareness: A Cross-Sectional Evaluation Using the RE-AIM Framework.
T. Fey, Theresa Herzig, Irina Rupp, U. Haidn +13 more
2026Journal of Cancer Education0 citations Open access
Semantic Scholar
Synergistic inhibition of low-grade serous ovarian cancer organoids by elacestrant and palbociclib: insights from a patient-derived organoid model for endocrine-targeted combination therapy
Fabian Bernhard Thaddäus Kraus, Q. Brumberger, P. Seidel, N. Topalov +8 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
Effektivität von T-DXd in der Therapie des Ovarialkarzinoms – Real World Daten einer Single Center-Analyse
A. Chelariu-Raicu, R. Ebner, V. Ivanov, A. König +12 more
2026Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
Altersassoziierte präkanzeröse DNA-Methylierungsveränderungen im tumorfreien Tubenepithel an zwischen STIC und HGSOC gemeinsamen Hyper-DHMRs
T. Zhang, L. Schröder, S. Mahner, F. Trillsch +1 more
2026Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
Combined high CEACAM1 and KRT17 expression identifies patients at increased risk of progression in high-grade serous ovarian cancer
S. Zhang, F. Kraus, C. Tauber, S. Mahner +3 more
2026Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
Treatment and outcome of elderly patients with presumed early ovarian cancer in Germany: real-world observations from the quality-assurance program of the AGO Study Group.
M. Pruss, F. Hilpert, P. Wimberger, Jacobus Pfisterer +11 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
T-DXd zur Therapie des rezidivierten, Her2-positiven Ovarialkarzinoms – Erfahrungen der LMU Frauenklinik
A. Chelariu-Raicu, R. Ebner, V. Ivanov, A. König +12 more
2026Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
[Hormone replacement therapy in gynecologic cancers: Balancing safety and quality of life].
H. Bralo, F. Trillsch, F. Hagemann, S. Mahner +1 more
2026MMW, Fortschritte der Medizin0 citations
Semantic Scholar
An open-label, randomized, multicenter, phase 3 study of trastuzumab deruxtecan with bevacizumab versus bevacizumab monotherapy as first-line maintenance therapy in HER2-expressing ovarian cancer: DESTINY-ovarian01
A. González-Martín, K. Hasegawa, Jo Marie Tran Janco, Jung-Yun Lee +8 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
Susac-Syndrom in der Schwangerschaft – interdisziplinäres Management eines seltenen Krankheitsbildes
C. V. Wagner, T. Kümpfel, S. Schrader, S. Mitter +4 more
2026Geburtshilfe und Frauenheilkunde0 citations
Semantic Scholar
123P Treatment and outcome of patients with relapsed ovarian cancer (OC) in Germany: QS Ovar of the AGO Study Group
F. Hilpert, A. du Bois, J. Pfisterer, S. Mahner +10 more
2026ESMO Open0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Trillsch×13
Invite
F. Trillsch — researcher profile on SciRah
P. Harter×11
Invite
P. Harter — researcher profile on SciRah
Mirjana Kessler×10
Invite
Mirjana Kessler — researcher profile on SciRah
B. Czogalla×9
Invite
B. Czogalla — researcher profile on SciRah

×9

Invite

A. Burges — researcher profile on SciRah

P. Wimberger×8

Invite

P. Wimberger — researcher profile on SciRah

Invite

J. Sehouli — researcher profile on SciRah

Invite

T. Kolben — researcher profile on SciRah

Invite

Doris Mayr — researcher profile on SciRah

Invite

F. Trillsch — researcher profile on SciRah

Invite

A. du Bois — researcher profile on SciRah

B. Schmalfeldt×5

Invite

B. Schmalfeldt — researcher profile on SciRah